Seaweeds as a potential resource in diabetes management: a review

Future Journal of Pharmaceutical Sciences

Table 1 Different seaweed species with their antidiabetic potential

Seaweed	Class	Bioactive compound used	Nature of study	Refs.
Sargassum kjellmanianum	Brown	Polysaccharide-alginate	In-vivo In-vitro	[42]
Ecklonia cava	Brown	Phlorotannin-Dieckol	In-vivo	[1]
Cystoseira compressa	Brown	phlorotannin	In-vivo	[43]
Laurencia dendroidea	Red	Bromophenols	α-glucosidase α-amylase	[44]
Sargassum confusum	Brown	oligosaccharides	In-vivo	[45]
Sargassum horneri	Brown	fucoidan	In-vivo	[46]
Macrocystis pyrifera	Brown	polysaccharide	In-vivo	[47]
Pelvetia siliquosa	Brown	Fucosterol	–	[48]
Grateloupia elliptica	Red	2,4,6-Tribromo phenol	α-Glucosidase inhibition	[49]
Polysiphonia morrowii	Red	3-Bromo-4,5-dihydroxy benzyl alcohol	α-Glucosidase inhibition	[50]
Gelidium amansii	Red	β-D-galactopyranose and 1,4-linked 3,6-anhydro-α-L-galactopyranose units	In-vivo	[51]
Gracilaria opuntia	Red	sulphated galactopyran	α-amylase and α-glucosidase inhibition	[32]
Hypnea spinella	Red	sulfated polysaccharide	In-vivo	[36]
Enteromorpha prolifera	Green	–	Inhibition of the JNK1/2 insulin pathway in liver of mice	[52]
Chaetomorpha aerea,	Green	–	Inhibition against alpha-amylase	[45]
Chlorodesmis	Green	z,z-6,2 8-heptatriactontadien-2-one	α-amylase inhibition	[45]